Xiaflex 0.9 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FFBP3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,586
Award facts
- Contract value 100% obligated
- $33,585.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $33,585.84 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xiaflex 0.9 mg vials. The delivery order, issued on December 4, 2025, with an ultimate completion date of December 26, 2025, carries no set-aside designation and was awarded competitively. DMS Pharmaceutical Group Inc. is the sole contractor on this award with no identified subcontractors.
This delivery order was issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy that establishes multiple regional prime vendor contractors to supply pharmaceutical products to Department of Defense healthcare facilities worldwide. The underlying PPV-G GEN V contract, valued at $499.999 billion with a completion date of December 31, 2036, authorizes DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, biologics, medical consumables, and over-the-counter medications to support military healthcare operations globally. The Xiaflex delivery exemplifies the company's established performance supplying specialized pharmaceutical products to federal military medical facilities.
Quick answers
Who was awarded contract SPE2DR26FFBP3?
SPE2DR26FFBP3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26FFBP3 worth?
The government has obligated $33,586 on SPE2DR26FFBP3.
Is contract SPE2DR26FFBP3 an order under another contract?
Yes. SPE2DR26FFBP3 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBP3 competed?
The extent of competition for SPE2DR26FFBP3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award